HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hakim Bouterfa Selected Research
Hakim Bouterfa Research Topics
Disease
6
Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2018 - 10/2003
4
Neoplasms (Cancer)
01/2018 - 10/2003
2
Neoplasm Metastasis (Metastasis)
01/2018 - 08/2003
2
Acromegaly
05/2009 - 06/2007
1
Arteritis
12/2020
1
Carcinoid Tumor (Carcinoid)
04/2010
1
Adenoma (Adenomas)
05/2009
1
Renal Insufficiency (Renal Failure)
10/2004
1
Nausea
02/2004
1
Vomiting
02/2004
1
Disease Progression
10/2003
Drug/Important Bio-Agent (IBA)
4
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
01/2018 - 10/2003
4
Octreotide (Sandostatin)
FDA Link
Generic
04/2010 - 04/2006
3
Edotreotide (SMT 487)
IBA
01/2018 - 10/2003
3
Somatostatin Receptors (Somatostatin Receptor)
IBA
01/2017 - 08/2003
3
Radioisotopes (Radionuclides)
IBA
12/2016 - 10/2004
2
Peptide Receptors (Peptide Receptor)
IBA
12/2016 - 04/2006
2
DOTA-Tyr(3)- 90Y-octreotide
IBA
02/2004 - 08/2003
1
68Ga-pentixafor
IBA
12/2020
1
Gallium-68
IBA
12/2020
1
Fluorine-18
IBA
12/2020
1
Ga(III)-DOTATOC
IBA
01/2018
1
177Lu-DOTA-JR11
IBA
01/2017
1
lutetium Lu 177 dotatate
IBA
01/2017
1
Interferons
IBA
04/2006
1
Creatinine
IBA
02/2004
1
Amino Acids
FDA Link
02/2004
1
amino-acid, glucose, and electrolyte solution (Novamine)
FDA Link
02/2004
1
pentetreotide (OctreoScan)
FDA Link
02/2004
1
Radiopharmaceuticals
IBA
10/2003
1
Indicators and Reagents (Reagents)
IBA
10/2003
1
Enzymes
IBA
08/2003
Therapy/Procedure
6
Therapeutics
12/2016 - 10/2003
1
Drug Therapy (Chemotherapy)
04/2006
1
Aftercare (After-Treatment)
10/2003